Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BioCopy Logo
BioCopy Growth Score
91
CB Rank
38838
Heat Score
70
BioCopy developed an innovative, patented technique to copy biomolecules analogous to a photocopier.
Founded
obfuscation
PrivateSeries A Freiburg, Baden-Wurttemberg, Germany1-10 www.biocopy.de
Biotechnology
Overview

BioCopy
Total Funding
obfuscation
Growth Score
91
Heat Score
70

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score91
-1 pts
in past quarter
Heat Score 70
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BioCopy

CB Rank
38838
BioCopy developed an innovative, patented technique to copy biomolecules analogous to a photocopier.
Founded
obfuscation
PrivateSeries A Freiburg, Baden-Wurttemberg, Germany1-10 www.biocopy.de
Biotechnology

Funding Rounds

Series A
OBF
in
obfuscation
Funding Round
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name BioCopy GmbH
Operating Status Active
Company Type For Profit
Founders  Christin Rath, Gunter Roth, Jurgen Burger
About the Company
BioCopy developed an innovative, patented technique to copy biomolecules analogous to a photocopier.
Contact Email info@biocopy.de
Predictions & Insights

Growth Insight

See this Growth Insight
BioCopy is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

AI-driven drug discovery and development platform
A proprietary platform utilizing artificial intelligence for the rapid discovery and development of cancer drug candidates.
ValidaTe precision screening technology
Technology for large-scale analysis of interactions between cancer cell markers and potential biotherapeutics, aiding in early safety and efficacy assessment.

Research & Development

BioCopy is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A
obfuscation
Series A - BioCopy Logo
Series A - BioCopy
1
obfuscation
Haute Capital PartnersSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4 Contacts 7

Employee Profiles

News

News and Press

News•Apr 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 26, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$152KThis year, BioCopy is projected to spend $152K on IT, according to Aberdeen.

Active Website Tech Count

14BioCopy is actively using 14 technologies for its website, according to BuiltWith. These include SSL by Default, CommonCrawl Top 50m, and  HSTS.

Total IP

17The intellectual property of BioCopy includes 12 registered patents primarily in the 'Physical Or Chemical Processes Or Apparatus In General' category, according to IPqwery. Additionally, BioCopy has registered 5 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is BioCopy's headquarters? BioCopy is located in Freiburg, Baden-Wurttemberg, Germany.Who invested in BioCopy? BioCopy has 2 investors including Haute Capital Partners and  EISMEA.When was the last funding round for BioCopy? BioCopy closed its last funding round on
obfuscation
from a Series A round.Who are BioCopy's competitors? Alternatives and possible competitors to BioCopy may include Absci, XtalPi, and  Generate Biomedicines.How much funding has BioCopy raised to date? BioCopy has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|